MedPath

THE EFFECT OF INTEGRATED REHABILITATION PROGRAM ON FATIGUE IN PATIENTS WITH PULMONARY TUBERCULOSIS

Phase 1
Completed
Conditions
Fatigue is a symptom frequently encountered in patients with pulmonary tuberculosis.No one has studied fatigue management programs in patients with pulmonary tuberculosis with clarity.
PULMONARY TUBERCULOSIS
INTEGRATED PROGRAM
LINE APPLICATION
FATIGUE
Registration Number
TCTR20221202001
Lead Sponsor
/A
Brief Summary

Before the experiment, The experimental group had a mean score of fatigue (mean 5.47, SD 1.99) and the control group (mean 5.46, SD 1.63). After the 3rd week of trial, the mean scores of the experimental group decreased (mean 4.56, SD 2.01) and the control group (mean 5.54, SD 1.92). At the end of the trial at week 6, the experimental group had mean score of fatigue (mean 3.52, SD 1.98) and the control group had mean score of fatigue.(mean 5.09, SD 2.03)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
68
Inclusion Criteria

Patients with pulmonary tuberculosis receiving antituberculosis drugs who were 18 years of age or older and had been treated for 2 weeks or more, experience with fatigue, ability to continue daily routines for at least 6 minutes without getting tired, no restrictions on walking and exercising, no cognitive impairment, ability to use the LINE application and communicate by speaking, reading and writing in Thai.

Exclusion Criteria

Patients with comorbidities causing simple fatigue, such as AIDS, cancer with chemotherapy or radiotherapy, emphysema, asthma Stage 4 kidney failure and up, congestive heart failure, a history of COVID-19 infection, a psychiatric disorder and sleep apnea.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fatigue Baseline, Week 3 and Week 6 (at the end of the study) Piper Fatigue Scale-12 (PFS-12)
Secondary Outcome Measures
NameTimeMethod
/A N/A N/A
© Copyright 2025. All Rights Reserved by MedPath